Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns

International Journal of STD and AIDS

Volumn 19, Issue 4, 2008, Pages 241-242

  Roedling, S A ^a   Reeves, I ^b   Copas, A J ^c   Beattie, A ^a   Edwards, S G ^a   Fisher, M ^b   Benn, P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UK   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antiretroviral drugs; HIV infection; PEPSE; Post exposure prophylaxis

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DATA BASE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEXUAL BEHAVIOR;

ANTI-HIV AGENTS; GUIDELINES AS TOPIC; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PUBLIC RELATIONS;

EID: 44349141158     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007216     Document Type: Article

References (9)

1. Giele CM, Maw R, Carne CA, Evans BG. 'Post-exposure prophylaxis for non-occupational exposure to HIV: current clinical practice and opinions in the UK'. Sex Transm Infect 2002;78:130-2
2. de Silva S, Miller RF, Walsh J. Lack of awareness of HIV post-exposure prophylaxis among HIV-infected and uninfected men attending an inner London clinic. Int J STD AIDS 2006;17:629-30
3. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyandGuidance/DH4083638 (last accessed 20/07/07)
4. Cardo DM, Culver DH, Ceisielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood: clinical and public health implications. N Engl J Med 1997;337:1485-90
5. Tsai CC, Emau P, Follis KE, Beck TW, et al. Effectiveness of post-inoculation PMPA treatment for the prevention of persistent SIV infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-73
6. Roland ME, Neilands TB, Krone MR, et al. Seroconversion following non occupational post exposure prophylaxis against HIV. CID 2005;41:1507-13
7. Benn P, Mercey D, Brink N, et al. Post-exposure prophylaxis using a nevirapine based regimen. Lancet 2001;357:687-8
8. Fisher M, Benn P, Evans B, et al. Clinical Effectiveness Group (British Association for Sexual Health and HIV). UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 2004;17:81-92
9. http://www.tht.org.uk/mediacentre/pressreleases/2004/july/ post-exposureprophylaxis.htm (last accessed 20/07/07)